§Upphandling · 719951-2025

StängdRamavtalPublicerad 30 okt 2025

DVD/240149 -Vaccine effectiveness, burden and impact studies

European Centre for Disease Prevention and Control, Solna

Uppskattat värde
330,4 mkr
Avtalstid
Ej angiven
Plats
Stockholms län
Förfarande
Öppet förfarande
Bransch (CPV)
Vård och socialtjänst 85100000

Från annons till sista anbudsdag

  1. Publicerad30 okt 2025
  2. Sista anbudsdag16 dec 2025
  3. I dag4 nov 2026

Beskrivning

Lot 1: Vaccine effectiveness, disease burden and impact studies using primary data in the hospital and primary care setting Work area 1: Vaccine effectiveness, disease burden and impact studies in the hospital setting (all age groups and including special populations), by building on the existing VEBIS hospital network. Work area 2: Vaccine effectiveness, disease burden and impact studies in the primary care setting (all age groups, special populations), by building on the existing VEBIS primary care network. Work area 3: Additional and ad hoc studies within the hospital and primary care setting. This work area can also be used for additional settings, for example those where there is exposure to infected animals or to an environment in which infected birds or animals are or have been present, e.g. for assessing VE against zoonotic influenza. Lot 2: Vaccine effectiveness, disease burden and impact studies using mainly Electronic Health Registries

Konkurrensbild

Fig. 1

Hård konkurrens. Liknande upphandlingar lockar många anbudsgivare.

Vård och socialtjänst, CPV 85100 · hela Sverige

9,4
anbud i snitt
13 %
fick bara ett anbud
40 mkr
medianvärde per avtal
43 %
vanns av små och medelstora

Beräknat 72 tilldelade kontrakt, senaste 36 mån

Ingår i Pro

Se hur konkurrensen ser ut i just det här länet.

Prova Pro gratis i 14 dagar

Fig. 2Flest vinster i kategorin – era troliga konkurrenter

Ingår i Pro

Se vilka leverantörer som vinner mest i kategorin – era troliga konkurrenter.

Prova Pro gratis i 14 dagar

Köparens tidigare avtal i samma område

Fig. 3